Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.56 % |
3 Month Return | + 14.94 % |
1 Year Return | + 25.75 % |
Market Stats | |
Previous Close | ₹93.00 |
Open | ₹93.00 |
Volume | 2,446.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹200.51Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹200.51 Cr |
P/B Ratio | -1.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹200.51 Cr | 0.01% | 0.96 | NA | NA | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Krebs Biochemicals & Industries Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Krebs Biochemicals & Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 37.5%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 159.9%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.76% of holdings in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.74% of holdings in Dec 2024 quarter
Price Dip
In the last 3 years, KREBSBIO stock has moved down by -56.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.74% | 0.00 | |
Foreign Institutions | 0.49% | 1.11 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.76% | 0.00 | |
Others | 0% |
Krebs Biochemicals & Industries Ltd’s net profit fell -61.34% since last year same period to ₹-5.76Cr in the Q2 2024-2025. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -11.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Krebs Biochemicals & Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.
Krebs Biochemicals & Industries Ltd share price today stands at ₹94.25, Open. ₹93 ; Previous Close. ₹93 ; High. ₹96 ; Low. ₹92.08 ; 52 Week High. ₹129.07 ; 52 Week Low: ₹60.35.
Krebs Biochemicals & Industries Ltd is listed on NSE
Krebs Biochemicals & Industries Ltd is listed on BSE
Today’s traded volume of Krebs Biochemicals & Industries Ltd(KREBSBIO) is 2,446.00.
Today’s market capitalisation of Krebs Biochemicals & Industries Ltd(KREBSBIO) is ₹200.51Cr.
Krebs Biochemicals & Industries Ltd(KREBSBIO | Price |
---|---|
52 Week High | ₹129.07 |
52 Week Low | ₹60.35 |
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹94.25. It is down -26.98% from its 52 Week High price of ₹129.07
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹94.25. It is up 56.17% from its 52 Week Low price of ₹60.35
Krebs Biochemicals & Industries Ltd(KREBSBIO | Returns |
---|---|
1 Day Returns | 1.25% |
1 Month Returns | -4.56% |
3 Month Returns | 14.94% |
1 Year Returns | 25.75% |